Sign up to save your podcasts
Or
Share New Viewpoints in the Management of IBD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
New Viewpoints in the Management of IBD
CME credits: 0.25
Valid until: 29-03-2022
Claim your CME credit at https://reachmd.com/programs/cme/new-viewpoints-in-the-management-of-ibd/12354/
New and emerging therapeutic targets will add to the existing portfolio of available biologics and small molecule therapies available in IBD. Join Dr. Russel Cohen and Dr. Neil Nandi as they explore the role of these targets in addressing the various unique IBD phenotypes that lead to loss of response over time, as well as provide practical insights into selecting the right therapy at the right time for your patient.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 29-03-2022
Claim your CME credit at https://reachmd.com/programs/cme/new-viewpoints-in-the-management-of-ibd/12354/
New and emerging therapeutic targets will add to the existing portfolio of available biologics and small molecule therapies available in IBD. Join Dr. Russel Cohen and Dr. Neil Nandi as they explore the role of these targets in addressing the various unique IBD phenotypes that lead to loss of response over time, as well as provide practical insights into selecting the right therapy at the right time for your patient.